Simplex Trading, LLC Mersana Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 72,844 shares of MRSN stock, worth $161,713. This represents 0.0% of its overall portfolio holdings.

Number of Shares

72,844

Previous 38,661 88.42%

Holding current value

$161,713

Previous $77,000 77.92%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$1.23 - $2.25 $42,045 - $76,911	34,183 Added 88.42%	72,844 $137,000
Q2 2024 Jul 25, 2024	BUY	$2.0 - $4.45 $61,242 - $136,263	30,621 Added 380.86%	38,661 $77,000
Q1 2024 Apr 25, 2024	BUY	$2.16 - $5.94 $4,801 - $13,204	2,223 Added 38.22%	8,040 $36,000
Q4 2023 Feb 02, 2024	SELL	$1.11 - $2.34 $6,052 - $12,760	-5,453 Reduced 48.39%	5,817 $13,000
Q3 2023 Nov 01, 2023	SELL	$1.06 - $3.91 $57,854 - $213,407	-54,580 Reduced 82.89%	11,270 $14,000
Q2 2023 Aug 04, 2023	BUY	$3.08 - $9.55 $62,548 - $193,941	20,308 Added 44.59%	65,850 $216,000
Q1 2023 Apr 27, 2023	BUY	$4.0 - $7.02 $169,808 - $298,013	42,452 Added 1373.85%	45,542 $187,000
Q4 2022 Feb 02, 2023	BUY	$5.65 - $7.86 $10,424 - $14,501	1,845 Added 148.19%	3,090 $18,000
Q3 2022 Nov 04, 2022	SELL	$4.63 - $8.0 $62,217 - $107,504	-13,438 Reduced 91.52%	1,245 $8,000
Q2 2022 Aug 03, 2022	SELL	$2.84 - $5.0 $7,091 - $12,485	-2,497 Reduced 14.53%	14,683 $67,000
Q1 2022 May 02, 2022	BUY	$3.74 - $6.63 $63,606 - $112,756	17,007 Added 9830.64%	17,180 $68,000
Q3 2021 Oct 28, 2021	SELL	$8.56 - $14.47 $856 - $1,447	-100 Reduced 36.63%	173 $2,000
Q2 2021 Aug 12, 2021	SELL	$13.28 - $18.07 $10,026 - $13,642	-755 Reduced 73.44%	273 $3,000
Q1 2021 Apr 26, 2021	SELL	$15.31 - $26.52 $17,070 - $29,569	-1,115 Reduced 52.03%	1,028 $16,000
Q4 2020 Feb 02, 2021	BUY	$16.84 - $27.59 $36,088 - $59,125	2,143 New	2,143 $57,000
Q3 2020 Oct 14, 2020	SELL	$16.2 - $25.7 $28,738 - $45,591	-1,774 Closed	0 $0
Q2 2020 Jul 13, 2020	BUY	$5.24 - $23.4 $9,295 - $41,511	1,774 New	1,774 $41,000

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $216M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Mersana Therapeutics, Inc. Transaction History